Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00201487

Choline Quantification in Breast Cancer by MRS

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
Female
Age
20 Years
Healthy volunteers
Not accepted

Summary

Choline has been found in increased concentration in breast cancer patients. Hypothesis: The choline signal as observed by MRS is sensitive to treatment, and a positive response to treatment will give a reduction in choline concentration. The purpose of this study is to establish methods for quantification of choline in breast cancer by MRS

Detailed description

1. Establishment of new MRS sequence for choline quantification of choline. This sequence is choline-selective, and signals from water and lipids are suppressed simultaneously. 2. Compare to different methods for choline quantification. The first method is quantification through an external phantom standard, containing a known concentration of choline. The other method is based on the utilisation of internal water signal as a reference. Both calculations can be performed from the same MR exam. Ten patients will be included in the study.

Conditions

Timeline

Start date
2007-11-01
Primary completion
2007-11-01
Completion
2007-11-01
First posted
2005-09-20
Last updated
2013-10-31

Source: ClinicalTrials.gov record NCT00201487. Inclusion in this directory is not an endorsement.

Choline Quantification in Breast Cancer by MRS (NCT00201487) · Clinical Trials Directory